|
1
|
Spigel DR, Hainsworth JD and Greco FA:
Neuroendocrine carcinoma of unknown primary site. Semin Oncol.
36:52–59. 2009.
|
|
2
|
Hess KR, Abbruzzese MC, Lenzi R, Raber MN
and Abbruzzese JL: Classification and regression tree analysis of
1000 consecutive patients with unknown primary carcinoma. Clin
Cancer Res. 5:3403–3410. 1999.
|
|
3
|
Lee HS, Han HS, Lim SN, et al: Poorly
differentiated neuroendocrine carcinoma in a perigastric lymph node
from an unknown primary site. Cancer Res Treat. 44:271–274.
2012.
|
|
4
|
Kim HY, Choi SI and Kim YH: Neuroendocrine
tumor of unknown primary accompanied with stomach adenocarcinoma. J
Gastric Cancer. 11:234–238. 2011.
|
|
5
|
Naswa N, Sharma P, Kumar A, et al:
68Ga-DOTANOC PET/CT in patients with carcinoma of
unknown primary of neuroendocrine origin. Clin Nucl Med.
37:245–251. 2012.
|
|
6
|
Miki K, Orita Y, Nose S, et al:
Neuroendocrine carcinoma of the larynx presenting as a primary
unknown carcinoma. Auris Nasus Larynx. 39:98–102. 2012.
|
|
7
|
de Bree R: The real additional value of
FDG-PET in detecting the occult primary tumour in patients with
cervical lymph node metastases of unknown primary tumour. Eur Arch
Otorhinolaryngol. 267:1653–1655. 2010.
|
|
8
|
Deron PB, Bonte KM, Vermeersch HF and Van
de Wiele C: Lymph node metastasis of squamous cell carcinoma from
an unknown primary in the upper and middle neck: Impact of
(18)F-fluorodeoxyglucose positron emission tomography/computed
tomography. Cancer Biother Radiopharm. 26:331–334. 2011.
|
|
9
|
Zhao K, Luo XM, Zhou SH, et al:
18F-fluorodeoxyglucose positron emission
tomography/computed tomography as an effective diagnostic workup in
cervical metastasis of carcinoma from an unknown primary tumor.
Cancer Biother Radiopharm. 27:685–693. 2012.
|
|
10
|
Prasad V, Ambrosini V, Hommann M, Hoersch
D, Fanti S and Baum RP: Detection of unknown primary neuroendocrine
tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl
Med Mol Imaging. 37:67–77. 2010.
|
|
11
|
Sobin LH and Wittekind CH: International
Union Against Cancer (UICC). TNM classification of malignant
tumours. 5th edition. Wiley-Liss; New York, NY: pp. 3361997
|
|
12
|
Stoyianni A, Pentheroudakis G and Pavlidis
N: Neuroendocrine carcinoma of unknown primary: a systematic review
of the literature and a comparative study with other neuroendocrine
tumors. Cancer Treat Rev. 37:358–365. 2011.
|
|
13
|
Ferlito A, Silver CE, Bradford CR and
Rinaldo A: Neuroendocrine neoplasms of the larynx: an overview.
Head Neck. 31:1634–1646. 2009.
|
|
14
|
Mikić A, Zvrko E, Trivić A, Stefanović D
and Golubović M: Small cell neuroendocrine tumor of the larynx - a
small case series. Coll Antropol. 36(Suppl 2): 201–204. 2012.
|
|
15
|
Møller AK, Loft A, Berthelsen AK, et al: A
prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools
to identify the primary tumor site in patients with extracervical
carcinoma of unknown primary site. Oncologist. 17:1146–1154.
2012.
|
|
16
|
Adams S, Baum R, Rink T, Schumm-Dräger PM,
Usadel KH and Hör G: Limited value of fluorine-18
fluorodeoxyglucose positron emission tomography for the imaging of
neuroendocrine tumours. Eur J Nucl Med. 25:79–83. 1998.
|
|
17
|
Song YS, Lee WW, Chung JH, Park SY, Kim YK
and Kim SE: Correlation between FDG uptake and glucose transporter
type 1 expression in neuroendocrine tumors of the lung. Lung
Cancer. 61:54–60. 2008.
|
|
18
|
Chen XH, Bao YY, Zhou SH, Wang QY and Zhao
K: Palatine tonsillar metastasis of small-cell neuroendocrine
carcinoma from the lung detected by FDG-PET/CT after tonsillectomy:
A case report. Iran J Radiol. 10:148–151. 2013.
|
|
19
|
Ozpacaci T, Tamam MO, Mulazimoglu M,
Kamali G and Ozcan D: Isolated adrenal metastasis of small cell
neuroendocrine carcinoma of the ovary detected with FDG-PET/CT. Rev
Esp Med Nucl Imagen Mol. 31:297–298. 2012.
|
|
20
|
Treglia G, Salomone E, Petrone G, Giaccari
A, Rindi G and Rufini V: A rare case of ectopic adrenocorticotropic
hormone syndrome caused by a metastatic neuroendocrine tumor of the
pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Clin Nucl
Med. 38:e306–e308. 2013.
|
|
21
|
Treglia G, Plastino F and Campitiello M:
Staging and treatment response evaluation in a metastatic
neuroendocrine tumor of the pancreas with G2 grading: insights from
multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC
PET/CT. Endocrine. 43:729–731. 2013.
|
|
22
|
Liu Y: FDG PET-CT demonstration of
metastatic neuroendocrine tumor of prostate. World J Surg Oncol.
6:642008.
|
|
23
|
Kim HJ and Hwang EG: Small cell carcinoma
of the larynx: imaging findings. Auris Nasus Larynx. 24:423–427.
1997.
|
|
24
|
Ferlito A and Rinaldo A: Primary and
secondary small cell neuroendocrine carcinoma of the larynx: a
review. Head Neck. 30:518–524. 2008.
|
|
25
|
Baugh RF, Wolf GT, Beals TF, Krause CJ and
Forastiere A: Small cell carcinoma of the larynx: results of
therapy. Laryngoscope. 96:1283–1290. 1986.
|
|
26
|
Ferlito A, Pesavento G, Recher G, et al:
Long-term survival in response to combined chemotherapy and
radiotherapy in laryngeal small cell carcinoma. Auris Nasus Larynx.
13:113–123. 1986.
|
|
27
|
Brennan SM, Gregory DL, Stillie A,
Herschtal A, Mac Manus M and Ball DL: Should extrapulmonary small
cell cancer be managed like small cell lung cancer? Cancer.
116:888–895. 2010.
|
